Vectura Group PLC | |
Stock Exchange | Other OTC |
EPS |
$0.17 |
Market Cap |
$699.62 M |
Shares Outstanding |
665.22 M |
Public Float |
- |
Vectura Group PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
665.3 M |
Public Float |
- |
Vectura Group PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.13 |
Market Cap |
GBP553.03 M |
Shares Outstanding |
665.3 M |
Public Float |
599.94 M |
Address |
1 Prospect West Chippenham Wiltshire SN14 6FH United Kingdom |
Employees | - |
Website | http://vectura.com |
Updated | 07/08/2019 |
Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. It operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. |